Summary:

Bio Protocol has introduced OpenLabs, a platform that combines AI-assisted research, collaboration, governance, and funding in one place.
Researchers can develop ideas, work with contributors, and seek funding through community voting powered by BIO token holders.
The launch builds on BIO Genesis, which has raised more than $33 million to support decentralized science (DeSci) projects.
OpenLabs aims to reduce dependence on traditional grant systems by giving researchers a faster and more open path to funding.
The platform was unveiled during DeSci.Berlin 2026 as Bio Protocol continues expanding its decentralized science ecosystem.

Scientific research often depends on lengthy grant applications, institutional review boards, and funding decisions that can take months before a project even begins. Bio Protocol believes there is a better way. The decentralized science (DeSci) project has officially launched OpenLabs, a platform that combines AI-assisted research development, collaboration, community governance, and funding into a single workspace. The announcement was made on June 19 during DeSci.Berlin 2026, held at KÖNIG GALERIE as part of Berlin Blockchain Week. OpenLabs brings those functions together inside one platform. Researchers can build projects with collaborators, receive AI assistance during development, and present proposals directly to the community for funding consideration. Announcing the launch on X, Bio Protocol described the vision behind the platform:

"we announced that Bio is building OpenLabs, a coordination and collaboration layer where humans and agents turn scientific ideas into funded execution.

What OpenLabs brings:

• A shared surface where humans and agents collaborate on scientific ideas

• Community voting and coordination that turns posts into funded projects

• BioAgents that maintain project continuity and drive research forward" Source

The announcement reflects a broader trend emerging across decentralized science, where blockchain infrastructure is increasingly being used to rethink how research is funded, coordinated, and shared. Instead of relying exclusively on traditional institutions, projects like OpenLabs aim to give researchers direct access to communities willing to support promising scientific work.

AI, community governance, and funding come together in one platform

OpenLabs is designed around the idea that research development and funding should happen within the same ecosystem. According to Bio Protocol, researchers can create and refine ideas with assistance from AI-powered workflows while collaborating with contributors throughout the development process. Once projects reach a suitable stage, they can be presented to the community, where BIO token holders participate in governance by voting on funding decisions. Instead of separating proposal writing, community discussion, governance, and capital allocation across multiple services, OpenLabs attempts to streamline those steps into one continuous process.

Bio Protocol says AI serves as a research assistant rather than a replacement for scientists. The platform is intended to help organize information, improve project planning, and support collaboration while leaving final scientific decisions to researchers and the wider community. During the launch, Bio Protocol highlighted several early examples of projects expected to operate within the ecosystem. One initiative, RheumaAI, focuses on developing an AI agent for rheumatology research. Another project, PeptAI, is dedicated to peptide discovery, an area of biotechnology with applications ranging from drug development to disease treatment. The platform's governance structure also gives BIO token holders a direct role in deciding which projects receive financial support. Rather than relying solely on centralized grant committees, OpenLabs introduces community participation into funding decisions while maintaining transparent on-chain governance. Although the launch generated interest within the decentralized science community, market conditions remained challenging. BIO traded more than 8% lower over the previous 24 hours, moving in line with weakness across the broader cryptocurrency market.

OpenLabs expands Bio Protocol's broader decentralized science vision

The launch of OpenLabs represents the latest step in Bio Protocol's broader effort to build infrastructure for decentralized scientific research. Over the past several years, the project has focused on creating tools that combine blockchain technology, tokenized intellectual property, decentralized autonomous organizations (BioDAOs), and community funding to support biotechnology research that might otherwise struggle to secure financing. One of the project's largest initiatives is BIO Genesis, which Bio Protocol says has now raised more than $33 million to support research organizations operating within its ecosystem. The project encourages broader participation from researchers, contributors, investors, and scientific communities. OpenLabs builds on that approach by providing the operational layer where ideas can move from early discussion to active development and eventually community-backed funding.

The concept reflects growing interest in decentralized science, often referred to as DeSci, a movement that applies blockchain technology to scientific publishing, intellectual property management, research funding, and collaboration. Supporters argue that decentralized models can improve transparency, reduce administrative barriers, and provide opportunities for researchers working outside traditional academic structures. Still, significant challenges remain. As projects mature from research concepts into commercial biotechnology ventures, they must navigate intellectual property rights, regulatory compliance, legal agreements, and healthcare regulations that vary across jurisdictions. Bio Protocol has acknowledged that these considerations will become increasingly important as more projects advance beyond early-stage research. Building sustainable governance frameworks, protecting research ownership, and ensuring regulatory compliance will likely play a larger role as decentralized science continues to evolve. For now, OpenLabs represents another attempt to make research funding more accessible by combining artificial intelligence, blockchain governance, and community participation within a single platform. Whether this model can complement or eventually reshape parts of the traditional grant system remains to be seen, but Bio Protocol is clearly positioning itself at the center of the growing DeSci ecosystem.